205 related articles for article (PubMed ID: 8417122)
21. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
[TBL] [Abstract][Full Text] [Related]
22. C1q in autoimmune diseases: rheumatoid arthritis.
Maeurer MJ; Trinder PK; Störkel S; Loos M
Behring Inst Mitt; 1993 Dec; (93):262-78. PubMed ID: 8172576
[TBL] [Abstract][Full Text] [Related]
23. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
24. The Fc-recognizing, collagen-like C1q molecule is a putative type II membrane protein of macrophages.
Kaul M; Loos M
Behring Inst Mitt; 1993 Dec; (93):171-9. PubMed ID: 8172565
[TBL] [Abstract][Full Text] [Related]
25. Activation of classical pathway of complement cascade by soluble oligomers of prion.
Dumestre-Pérard C; Osmundson J; Lemaire-Vieille C; Thielens N; Grives A; Favier B; Csopaki F; Jamin M; Gagnon J; Cesbron JY
Cell Microbiol; 2007 Dec; 9(12):2870-9. PubMed ID: 17991046
[TBL] [Abstract][Full Text] [Related]
26. Interaction of C1 with HIV-1.
Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
Behring Inst Mitt; 1993 Dec; (93):165-70. PubMed ID: 8172563
[TBL] [Abstract][Full Text] [Related]
27. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
28. Nonimmune activation of the classical complement pathway.
Gewurz H; Ying SC; Jiang H; Lint TF
Behring Inst Mitt; 1993 Dec; (93):138-47. PubMed ID: 8172561
[No Abstract] [Full Text] [Related]
29. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
30. Binding of human serum amyloid P-component to phosphocholine.
Christner RB; Mortensen RF
Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
[TBL] [Abstract][Full Text] [Related]
31. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
Pisalyaput K; Tenner AJ
J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
[TBL] [Abstract][Full Text] [Related]
32. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
33. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase.
Sørensen IJ; Nielsen EH; Andersen O; Danielsen B; Svehag SE
Scand J Immunol; 1996 Oct; 44(4):401-7. PubMed ID: 8845035
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid P component forms a stable complex with human C5b6.
Barbashov SF; Wang C; Nicholson-Weller A
J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the binding of serum amyloid P to type IV collagen.
Zahedi K
J Biol Chem; 1996 Jun; 271(25):14897-902. PubMed ID: 8662978
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of SAP and CRP, two pentraxins from Pangasianodon (Pangasius) hypophthalmus.
Huong Giang DT; Van Driessche E; Vandenberghe I; Devreese B; Beeckmans S
Fish Shellfish Immunol; 2010; 28(5-6):743-53. PubMed ID: 20109557
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins.
Hillarp A; Wiklund H; Thern A; Dahlbäck B
J Immunol; 1997 Feb; 158(3):1315-23. PubMed ID: 9013975
[TBL] [Abstract][Full Text] [Related]
40. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production.
Ruiz S; Henschen-Edman AH; Tenner AJ
J Biol Chem; 1995 Dec; 270(51):30627-34. PubMed ID: 8530499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
